As Director of EU Regulatory Policy, Simon is responsible for developing and leading Biogen’s European regulatory policy activities, including agenda-setting and prioritisation and representing Biogen in interactions with EU Trade Associations and regulators on key issues, including the European Regulatory Affairs and Operations (ERAO) Variations Subgroup. Simon began working for Biogen in 2003 within the clinical operations group, focusing on the initiation and management of clinical trial activities primarily in multiple sclerosis (MS) and other neurological conditions. In early 2008, Simon moved into Biogen’s regulatory group and has undertaken a number of senior regulatory roles within that function. Prior to joining Biogen, Simon worked in medical communications and publishing in areas of schizophrenia and infectious diseases. Simon is a biologist by training with an MSc in medical parasitology.